Chitosanase mutant with altered degree of polymerization of product and use thereof
By performing site-directed mutagenesis on chitosanase BsCsn46A, chitosan oligosaccharide COS4 was generated, which solved the problem of insufficient antibacterial properties of chitosan oligosaccharide in the existing technology and realized the efficient preparation of chitosan oligosaccharide with high antibacterial activity.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- CHANGZHOU UNIV
- Filing Date
- 2023-06-16
- Publication Date
- 2026-07-21
AI Technical Summary
There is limited research on existing chitosanases for preparing chitosan oligosaccharides with a specified degree of polymerization, making it difficult to generate chitosan oligosaccharide COS4 with high antibacterial activity.
By performing a site-directed mutation at position 50 of the amino acid sequence of chitosanase BsCsn46A, threonine was mutated to alanine (T50A) or tryptophan (T50W), respectively, to prepare chitosanase mutants COS2 and COS3, which were then used to generate COS4 during the catalytic hydrolysis of chitosan.
A large amount of chitosan oligosaccharide COS4 with high antibacterial function was generated, which significantly improved the antibacterial properties of chitosan oligosaccharide.
Smart Images

Figure FT_1 
Figure FT_2